この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2000/3/281 分で読めます
John J. Ferrante et al.; Proposal to Withdraw Approval of 158 Abbreviated New Drug Applications; Opportunity for a Hearing
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on the agency's proposal to withdraw approval of 158 abbreviated new drug applications (ANDA's). The basis for the proposal is that the sponsors have repeatedly failed to file required annual reports for these applications.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →